| Trial ID: | L0110 |
| Source ID: | NCT01677325
|
| Associated Drug: |
YiQiSanJu
|
| Title: |
The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD( Non-alcoholic Fatty Liver Disease )
|
| Interventions: |
Drug: Chinese herb (YiQiSanJu)
|
| Outcome Measures: |
The CT ratio of liver/spleen|BMI(Body Mass Index )|liver function|lipid profile|NEFA(nonesterified fatty acid)|HOMA index|adiponectin|IL-6(interleukin 6)|hs-CRP (C-reactive protein)|TNF??( tumor necrosis factor-??)|leptin
|
| Sponsor/Collaborators: |
Fudan University
|
| Gender: |
Male
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
40
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Treatment
|
| Start Date: |
January 2007
|
| Completion Date: |
January 2008
|
| Results First Posted: |
--
|
| Last Update Posted: |
September 5, 2012
|
| Locations: |
--
|
| URL: |
https://ClinicalTrials.gov/show/NCT01677325
|
